Involvement of both L- and N-type voltage-dependent Ca2+ channels in KCl- and veratridine-evoked transmitter release from non-adrenergic, non-cholinergic nerves in the rabbit iris sphincter muscle

Naunyn Schmiedebergs Arch Pharmacol. 1997 May;355(5):638-44. doi: 10.1007/pl00004995.

Abstract

To determine which types of voltage-dependent Ca2+ channels mediate tachykinin release in the isolated rabbit iris sphincter muscle, we examined the effects of several Ca2+ channel modulators on contractions induced by either an elevation of the extracellular KCl concentration or application of the Na+ channel activator veratridine. Contractions caused by either 45.9 mM KCl or veratridine (10 microM) were inhibited by spantide (10 microM), a tachykinin receptor antagonist, and capsaicin (10 microM), a tachykinin-depleting agent, but were not changed by atropine. Nicardipine, an L-type Ca2+ channel blocker, inhibited contractions induced by KCl and veratridine in a concentration-dependent manner. omega-Conotoxin GVIA (1 microM), an N-type Ca2+ channel blocker, inhibited only contractions induced by lower concentrations of KCl, both when applied alone and when combined with nicardipine. Bay K 8644, an L-type Ca2+ channel activator, caused a spantide- and nicardipine-sensitive contraction in muscles partially depolarized with 15.9 mM KCl, and enhanced contractions induced by 15.9 mM KCl and veratridine (2 microM). omega-Agatoxin IVA (0.3 microM), a P-type voltage-dependent Ca2+ channel blocker, did not affect contractions induced by either KCl or veratridine. Contractions induced by exogenous substance P were not modified by any of the Ca2+ channel blockers or by Bay K 8644. These results suggest that, in the rabbit iris sphincter muscle. L- and N-type voltage-dependent Ca2+ channels are involved in neurotransmitter release from tachykininergic nerves elicited by high KCl and by veratridine.

MeSH terms

  • 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester / pharmacology
  • Analgesics / pharmacology
  • Animals
  • Atropine / pharmacology
  • Calcium Channel Blockers / pharmacology*
  • Calcium Channels / classification
  • Calcium Channels / drug effects*
  • Calcium Channels / metabolism
  • Capsaicin / pharmacology
  • Iris / drug effects*
  • Iris / innervation
  • Iris / metabolism
  • Male
  • Muscarinic Antagonists / pharmacology
  • Muscle Contraction / drug effects
  • Muscle, Smooth / drug effects*
  • Nicardipine / pharmacology
  • Peptides / pharmacology
  • Potassium Chloride / pharmacology*
  • Rabbits
  • Receptors, Tachykinin / antagonists & inhibitors
  • Sodium Channels / drug effects
  • Spider Venoms / pharmacology
  • Substance P / analogs & derivatives
  • Substance P / pharmacology
  • Synaptic Transmission / drug effects
  • Veratridine / pharmacology*
  • omega-Agatoxin IVA
  • omega-Conotoxin GVIA

Substances

  • Analgesics
  • Calcium Channel Blockers
  • Calcium Channels
  • Muscarinic Antagonists
  • Peptides
  • Receptors, Tachykinin
  • Sodium Channels
  • Spider Venoms
  • omega-Agatoxin IVA
  • Substance P
  • Potassium Chloride
  • Veratridine
  • 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
  • Atropine
  • spantide
  • omega-Conotoxin GVIA
  • Nicardipine
  • Capsaicin